1. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis. (15th May 2020) Authors: Kalachand, Roshni D; Stordal, Britta; Madden, Stephen; Chandler, Benjamin; Cunningham, Julie; Goode, Ellen L; Ruscito, Ilary; Braicu, Elena I; Sehouli, Jalid; Ignatov, Atanas; Yu, Herbert; Katsaros, Dionyssios; Mills, Gordon B; Lu, Karen H; Carey, Mark S; Timms, Kirsten M; Kupryjanczyk, Jolanta; ... Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 12(2020) Page Start: 1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer – a population-based study. (3rd July 2021) Authors: Scharl, Sophia; Gerken, Michael; Sprötge, Tim; Kronberger, Karin; Scharl, Anton; Ignatov, Atanas; Ortmann, Olaf; Kölbl, Oliver; Klinkhammer-Schalke, Monika; Papathemelis, Thomas Journal: Acta oncologica Issue: Volume 60:Number 7(2021) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Contralateral lymph node metastases in patients with vulvar cancer and unilateral sentinel lymph node metastases. (19th June 2021) Authors: Ignatov, Tanja; Gaßner, Johannes; Bozukova, Mihaela; Ivros, Stylianos; Mészáros, József; Ortmann, Olaf; Eggemann, Holm; Ignatov, Atanas Journal: Acta obstetricia et gynecologica Scandinavica Issue: Volume 100:Number 8(2021) Page Start: 1520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Endometrial cancer after ulipristal acetate for uterine fibroma. (December 2017) Authors: Ignatov, Tanja; Eggemann, Holm; Dan Costa, Serban; Ignatov, Atanas Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 219(2017) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients. (7th February 2017) Authors: Weissenborn, Christine; Ignatov, Tanja; Nass, Norbert; Kalinski, Thomas; Dan Costa, Serban; Zenclussen, Ana Claudia; Ignatov, Atanas Journal: Cancer investigation Issue: Volume 35:Number 2(2017) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GPER-1 Expression Decreases During Breast Cancer Tumorigenesis. (1st June 2013) Authors: Ignatov, Tanja; Weißenborn, Christine; Poehlmann, Angela; Lemke, Antje; Semczuk, Andrzej; Roessner, Albert; Costa, Serban Dan; Kalinski, Thomas; Ignatov, Atanas Journal: Cancer investigation Issue: Volume 31:Number 5(2013) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. GPER-1 Expression Decreases During Breast Cancer Tumorigenesis. (1st June 2013) Authors: Ignatov, Tanja; Weißenborn, Christine; Poehlmann, Angela; Lemke, Antje; Semczuk, Andrzej; Roessner, Albert; Costa, Serban Dan; Kalinski, Thomas; Ignatov, Atanas Journal: Cancer investigation Issue: Volume 31:Number 5(2013) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Role of tumour-free margin distance for loco-regional control in vulvar cancer—a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. (December 2016) Authors: Woelber, Linn; Griebel, Lis-Femke; Eulenburg, Christine; Sehouli, Jalid; Jueckstock, Julia; Hilpert, Felix; de Gregorio, Nikolaus; Hasenburg, Annette; Ignatov, Atanas; Hillemanns, Peter; Fuerst, Sophie; Strauss, Hans-Georg; Baumann, Klaus H.; Thiel, Falk C.; Mustea, Alexander; Meier, Werner; Hart... Journal: European journal of cancer Issue: Volume 69(2016) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. (16th September 2021) Authors: Gerthofer, Valeria; Scheiter, Alexander; Lüke, Florian; Keil, Felix; Utpatel, Kirsten; Pöhmerer, Laura-Maria-Giovanna; Seitz, Johannes; Niessen, Christoph; Ignatov, Atanas; Dietmaier, Wolfgang; Calvisi, Diego F.; Evert, Matthias; Ortmann, Olaf; Seitz, Stephan Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. (2021) Authors: Gerthofer, Valeria; Scheiter, Alexander; Lüke, Florian; Keil, Felix; Utpatel, Kirsten; Pöhmerer, Laura-Maria-Giovanna; Seitz, Johannes; Niessen, Christoph; Ignatov, Atanas; Dietmaier, Wolfgang; Calvisi, Diego F.; Evert, Matthias; Ortmann, Olaf; Seitz, Stephan Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗